Comparable Efficacy and Tolerability of Formoterol (Foradil®) Administered via a Novel Multi-Dose Dry Powder Inhaler (Certihaler™) or the Aerolizer® Dry Powder Inhaler in Patients with Persistent Asthma

Background: For maximum treatment compliance there is a need to provide asthma patients with devices that suit their particular preferences. The Foradil ® Certihaler™ is a novel multi-dose dry powder inhaler developed to increase the choice of devices available. Objectives: To evaluate the safety an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Respiration 2004-03, Vol.71 (2), p.126-133
Hauptverfasser:	Dahl, R., Creemers, J.P., van Noord, J., Sips, A., Della Cioppa, G., Thomson, M., Andriano, K., Kottakis, J., Fashola, T.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Inhalation Adolescent Adult Aged Area Under Curve Asthma Asthma - drug therapy Biological and medical sciences Bronchodilator Agents - administration & dosage Bronchodilator Agents - adverse effects Bronchodilator Agents - pharmacokinetics Bronchodilator Agents - urine Chronic obstructive pulmonary disease, asthma Clinical Investigations Clinical trials Comparative analysis Cross-Over Studies Dose-Response Relationship, Drug Double-Blind Method Drug Administration Schedule Ethanolamines - administration & dosage Ethanolamines - adverse effects Ethanolamines - pharmacokinetics Ethanolamines - urine Female Forced Expiratory Volume - drug effects Formoterol Fumarate Humans Male Medical sciences Middle Aged Nebulizers and Vaporizers Pneumology Powders Respiratory diseases Respiratory Tract Infections - chemically induced Treatment Outcome Tremor - chemically induced
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!